KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Exchange Rate Effect (2016 - 2025)

Eli Lilly (LLY) has disclosed Exchange Rate Effect for 17 consecutive years, with -$67.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect rose 84.35% year-over-year to -$67.1 million, compared with a TTM value of $372.0 million through Dec 2025, up 225.25%, and an annual FY2025 reading of $372.0 million, up 225.25% over the prior year.
  • Exchange Rate Effect was -$67.1 million for Q4 2025 at Eli Lilly, down from $31.7 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $275.5 million in Q2 2025 and bottomed at -$428.8 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is -$6.5 million, with a median of $7.0 million recorded in 2021.
  • The sharpest move saw Exchange Rate Effect tumbled 906.98% in 2022, then soared 4181.13% in 2024.
  • Year by year, Exchange Rate Effect stood at -$220.7 million in 2021, then surged by 41.91% to -$128.2 million in 2022, then skyrocketed by 201.17% to $129.7 million in 2023, then plummeted by 430.61% to -$428.8 million in 2024, then soared by 84.35% to -$67.1 million in 2025.
  • Business Quant data shows Exchange Rate Effect for LLY at -$67.1 million in Q4 2025, $31.7 million in Q3 2025, and $275.5 million in Q2 2025.